Livtencity Drug Interactions
Currently displaying a list of 140 drugs known to interact with Livtencity (maribavir).
- 18 major drug interactions
- 116 moderate drug interactions
- 6 minor drug interactions
Medications known to interact with Livtencity
Note: Showing generic names only.
A
B
C
D
E
- efavirenz
- elacestrant
- elafibranor
- elagolix
- eltrombopag
- empagliflozin
- encorafenib
- enfortumab vedotin
- enzalutamide
- eslicarbazepine
- etravirine
- everolimus
F
G
I
L
M
- mavacamten
- mavorixafor
- mephobarbital
- methotrexate
- metreleptin
- mitapivat
- mitotane
- mobocertinib
- modafinil
N
O
P
- pacritinib
- palovarotene
- pemigatinib
- pentobarbital
- pexidartinib
- phenobarbital
- phenylbutazone
- phenytoin
- pirtobrutinib
- pitolisant
- pralsetinib
- primidone
Q
R
- repotrectinib
- revumenib
- rifabutin
- rifampin
- rifapentine
- riociguat
- ripretinib
- ritlecitinib
- rivaroxaban
- roflumilast topical
- rosuvastatin
- rucaparib
- rufinamide
S
- secobarbital
- seladelpar
- selexipag
- sildenafil
- sirolimus
- sirolimus protein-bound
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotorasib
- sparsentan
- st. john's wort
- sulfasalazine
- sulfinpyrazone
- suzetrigine
T
- tacrolimus
- talazoparib
- tazemetostat
- tecovirimat
- telotristat
- temsirolimus
- teriflunomide
- thiotepa
- topotecan
- tovorafenib
- trofinetide
- troglitazone
U
V
Livtencity disease interactions
There are 2 disease interactions with Livtencity (maribavir) which include:
More about Livtencity (maribavir)
- Livtencity consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antivirals
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.